Researchers from the University of Rochester Medical Center experimented successfully for the discovery of antibodies that prevent the growth of Methicilin Resistant Staphylococcus Aureus (MRSA) in the human bodies.

In a radical discovery scientists found the monoclonal antibodies namely Glucosaminidase (GMD), which are helpful in dislocating the spread of bacteria.

Edward Schwarz, who led the study, said that although vaccine cannot be relied upon as a 100% protection against the infection but even the risk reduction by as low as 35% matters a lot.

The current research for the vaccination aims at preventing the closing of the protein `zipper' after cell division so as to create lethal environment for the bacteria.

In the past, similar researches were made but they were not as successful because of the lack for an agent that could break through the MRSA's unique cell wall shield.

But, now with the discovery of antibodies, it is speculated that major and effective treatments can be worked upon against the superbug.

MRSA is a dangerous bacterium, which leads to many incurable diseases in humans. It is resistant to many antibiotics, thereby making it more difficult to treat the patients.

People with open wounds or weakened immune system are at the highest risk of getting infected, resulting in no less than 19,000 deaths in US itself.